PeptidesWeight LossLongevitySexual Health - MenSexual Health - WomenHair RestorationAnti-ParasiticSleepHow it worksFAQAboutContactLog in
Peptide therapy · Provider-reviewed peptide protocol
PrescriptionU.S. Licensed PharmacyProvider-ReviewedEvidence Explained

KPV: a three-amino-acid alpha-MSH fragment

KPV is a synthetic tripeptide fragment of alpha-melanocyte-stimulating hormone. Cell and animal research has explored PepT1 transport and inflammatory signaling. Human safety, effectiveness, and dosing have not been established.

Coming soonComing soon
✓ U.S.-licensed providers✓ HIPAA-secure✓ Free discreet shipping✓ Ongoing care included
KPV product image
Mechanism and evidence

What the research says about KPV

Mechanism education without turning preclinical findings into promises.

✓

An alpha-MSH fragment

KPV is the Lys-Pro-Val tripeptide fragment of alpha-melanocyte-stimulating hormone. It is a defined peptide sequence, not the full parent hormone.

✓

PepT1 and inflammatory signaling

In intestinal epithelial and immune-cell experiments, researchers studied KPV transport through PepT1 and its relationship to NF-kB and MAP-kinase signaling. These are preclinical mechanism findings.

✓

No established human evidence

FDA identified no human exposure data, human pharmacokinetic studies, or clinical trials for KPV. Animal and ex-vivo findings do not establish human benefits, and one 2026 mouse study found no benefit from oral free KPV on reported disease measures.

✓

Protocol details require review

A licensed provider must determine whether a compounded KPV protocol is appropriate. This option is coming soon. Pricing and protocol details will be confirmed when it opens.

About this treatment

Provider-reviewed care, built around the evidence

✓

Provider oversight

Prescribed only when a licensed provider determines it is appropriate based on your history, medications, and treatment goals.

✓

No mystery vials

When prescribed, your medication is prepared by and shipped directly from a licensed U.S. pharmacy in discreet packaging.

✓

Clear ingredient education

Each product page separates mechanism research from human evidence so the unknowns stay visible.

✓

Ongoing care included

Message your care team with questions about your protocol, refills, or side effects.

How it works

Care without the waiting room

Get started in 4 simple steps. No office visits required.

01

Start your assessment

A 5-minute online health questionnaire, no appointment, no waiting room.

02

Provider review

A licensed provider in your state reviews your history and prescribes if appropriate.

03

Pharmacy ships direct

When prescribed, your medication ships from a licensed U.S. pharmacy in discreet packaging.

04

Ongoing support

Message your care team anytime. Dose questions and refills are handled online.

FAQ

Questions about KPV

What does the research actually show?

KPV evidence is preclinical. FDA identified no human administration data, and findings from engineered proKPV compounds cannot be attributed to free KPV.

Is this medication FDA-approved?

No. This compounded medication is not FDA-approved. Compounded drugs are prepared for individual patients, and FDA does not verify their safety, effectiveness, or quality before marketing.

How do I know whether it is appropriate for me?

When this option opens, a licensed provider will review your medical history, medications, and goals before deciding whether to prescribe.

Where will I see pricing and protocol details?

This option is coming soon. Pricing and provider-directed protocol details will be confirmed when it opens.

Important safety informationWhen available, KPV will be prescribed only after evaluation by a licensed provider. This compounded medication is not FDA-approved; the FDA does not verify the safety, effectiveness, or quality of compounded drugs. Common side effects, interactions, and long-term risks are unknown because FDA identified no human exposure data. Allergic and formulation-related reactions cannot be ruled out. FDA has also identified inadequate information about immunogenicity, aggregation, and toxicology. Tell your provider about all medical conditions and medications and report unexpected symptoms. KPV is not named individually in the 2026 WADA list, but WADA S0 can apply to non-approved substances; tested athletes should verify status with their anti-doping organization. Individual results vary. This page is educational and is not medical advice.
Peptide therapy

Related treatments

BPC-157 product image

BPC-157

Subcutaneous injection

15 amino acids. One injectable protocol.

From $188 first month
TB-500 product image

TB-500

Subcutaneous injection

Thymosin beta-4 fragment. Injectable protocol.

From $199 first month
Coming soonEpitalon product image

Epitalon

Provider-reviewed peptide protocol

Four amino acids. One synthetic peptide.

Coming soon